< Back to latest news & events

Event

Stevenage Bioscience Catalyst webinar; Intellectual Property: Are you infringing?

September 2020

Event date: 11th September 2020

Stevenage Bioscience Catalyst is holding a webinar on 11th September which will be hosted by HGF Partner Kerry Rees.

Intellectual Property: Are you infringing?

Navigating your way through third party IP rights

Join HGF Partner Kerry Rees and Stevenage Bioscience Catalyst on 11th September at 12pm to hear Kerry discussing patent infringement and freedom to operate in the life science area. The webinar will include:

  • Introduction to HGF
  • Patent infringement
  • Freedom to operate and infringement risk
  • Questions and closing remarks (introduction to proposed due diligence workshop)
Find out more

Attendees

Kerry
Rees

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
See all updates